@ASP_Chat Vabomere (2017, Melinta) for CRE infections!! Found to have higher cure rates and lower 28 day mortality than current best available therapy. Also a better safety profile and less nephrotoxicity https://t.co/5ftTQkMQKZ
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
Great to hear all the discussion around the TANGO II paper published in our journal @IDWeek2018 #IDWeek2018
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @UVA_ID: Congrats to UVA ID's Dr. Amy Mathers and her colleagues on this important work! https://t.co/dfASraDMyj
RT @etevalf: Muy interesante lo que llega... Y se compara vs el mejor/mejores tratamientos disponibles!! https://t.co/aMWl1VZeGV
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @etevalf: Muy interesante lo que llega... Y se compara vs el mejor/mejores tratamientos disponibles!! https://t.co/aMWl1VZeGV
RT @UVA_ID: Congrats to UVA ID's Dr. Amy Mathers and her colleagues on this important work! https://t.co/dfASraDMyj
RT @UVA_ID: Congrats to UVA ID's Dr. Amy Mathers and her colleagues on this important work! https://t.co/dfASraDMyj
Congrats to UVA ID's Dr. Amy Mathers and her colleagues on this important work!
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. https://t.co/Ldiwc0mqZF #cre #crkp #AMR
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @SIDPharm: Need a little light reading for the ride to San Francisco for #SIDP2018 #IDWeek2018 ? TANGO II is out! https://t.co/EoSq9DKpNh
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
Muy interesante lo que llega... Y se compara vs el mejor/mejores tratamientos disponibles!!
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. https://t.co/Tfiyi3ZN1g https://t.co/ufB0wxTKY7
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @SIDPharm: Need a little light reading for the ride to San Francisco for #SIDP2018 #IDWeek2018 ? TANGO II is out! https://t.co/EoSq9DKpNh
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @SIDPharm: Need a little light reading for the ride to San Francisco for #SIDP2018 #IDWeek2018 ? TANGO II is out! https://t.co/EoSq9DKpNh
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @SIDPharm: Need a little light reading for the ride to San Francisco for #SIDP2018 #IDWeek2018 ? TANGO II is out! https://t.co/EoSq9DKpNh
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
Need a little light reading for the ride to San Francisco for #SIDP2018 #IDWeek2018 ? TANGO II is out!
RT @littlebugdrug: TANGO II !💃 love to see trials vs. BAT #CRE https://t.co/8uyawNfgdJ
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
Meropenem/varbobactam demostrando superioridad vs terapias actuales en enterobacterias R a carbapenemicos @idelama
TANGO II !💃 love to see trials vs. BAT #CRE
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
RT @ABsteward: JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-A…
JUST Published 🔥🔥 TANGO II RCT by @Keith_S_Kaye in @InfectDis_Ther Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The Randomized Clinical Trial #vabomere htt